RT Journal Article
SR Electronic
T1 1396 TriTCE CPI: a novel trispecifc T cell engager platform with integrated PD-1/PD-L1 checkpoint inhibition engineered for the treatment of immunosuppressed tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1551
OP A1551
DO 10.1136/jitc-2023-SITC2023.1396
VO 11
IS Suppl 1
A1 Verstraete, Meghan M
A1 Poffenberger, Maya
A1 Zago, Matteo
A1 Luu, Veronica
A1 Ma, Brenda
A1 Escalante, Nichole
A1 Li, Janessa
A1 Escanda, Diego Perez
A1 Cao, Siran
A1 Meier, Edward
A1 Arrafi, Sifa
A1 Peng, Yun
A1 Rossum, Anna Von
A1 Desjardins, Genevieve
A1 Weisser, Nina
A1 Kreudenstein, Thomas Spreter von
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1551.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.